Onconetix, Inc. (ONCO) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Onconetix, Inc. (ONCO), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Onconetix, Inc., analysts forecast revenue rising from $58,000 in 2023 to $952,384 in 2027; the average estimate for 2027 earnings per share is −$2142000.00; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Onconetix, Inc. (ONCO) forecast — frequently asked questions
What are analysts forecasting for Onconetix, Inc.'s earnings?
The average analyst estimate for Onconetix, Inc. (ONCO) earnings per share in 2027 is -2142000.00, with individual estimates between -2142000.00 and -2142000.00.
How much revenue is Onconetix, Inc. expected to make?
Analysts forecast Onconetix, Inc. (ONCO) revenue of $952,384 in 2027, based on 1 published estimates.
How many analysts cover ONCO?
1 analyst contribute estimates for Onconetix, Inc. (ONCO). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.